Majid Ebrahimi Warkiani

Prof. Majid Ebrahimi Warkiani is a Professor of Biomedical Engineering at the University of Technology Sydney (UTS), leading the Warkiani Lab. He holds a PhD from Nanyang Technological University (Singapore) and completed postdoctoral training at MIT (USA). His roles include academic leadership, grant coordination (totaling over $12M), and advisory board memberships in biotech companies.

Education & Career:

• PhD in Mechanical Engineering (Nanyang Technological University, Singapore)
• Postdoctoral Research at MIT (USA)
• Fellowships: NRF (2012-2014), NHMRC (2018-2022), Cancer Institute NSW (2022-2025)

Research Interests: Focuses on three core areas:

1. Microfluidics for cell sorting (e.g., circulating tumor cells, fetal cells)
2. Organ-on-a-chip systems for disease modeling (lung-on-a-chip, tumor-on-a-chip)
3. 3D micro-printing for biomedical applications (micromixers, microfilters)

His lab bridges academia and industry, collaborating with partners like 23Strands and Regeneus.

Key Contributions:

• Developed microfluidic technologies for liquid biopsy (e.g., ctDNA and CTC isolation)
• Pioneered sperm selection devices for IVF
• Founded startups NeoGenix Biosciences and SMART MCs

Awards & Recognition:

• Young Tall Poppy Science Award (2019)
• MIT Technology Review Innovators under 35 (2016)
• Nanyang Young Alumni Award (2017)

Grants & Funding:

• ARC Discovery Projects, NHMRC Fellowships, and industry partnerships
• Established Australia-China Joint Research Centre for Point-of-Care Testing (2019)

Labs & Teams: The Warkiani Lab is a hub for multidisciplinary research, emphasizing translational impact. It has produced award-winning PhD students and advanced technologies like microfluidic biochips used globally.